Type your tag names separated by a space and hit enter

Azotemia and Urinary Abnormalities

Azotemia and Urinary Abnormalities is a topic covered in the Harrison's Manual of Medicine.

To view the entire topic, please or purchase a subscription.

Harrison’s Manual of Medicine 19th edition provides 600+ internal medicine topics in a rapid-access format. Download Harrison’s App to iPhone, iPad, and Android smartphone and tablet. Explore these free sample topics:

Harrison’s Manual of Medicine - App + Web

-- The first section of this topic is shown below --


Azotemia is the retention of nitrogenous waste products excreted by the kidney. Increased levels of blood urea nitrogen (BUN) (>10.7 mmol/L [>30 mg/dL]) and creatinine (>133 μmol/L [>1.5 mg/dL]) are ordinarily indicative of impaired renal function. Renal function can be estimated by determining the clearance of creatinine (CLcr) (normal >100 mL/min); this can be directly measured from a 24-h urine collection using the following equation:

Creatinine clearance (mL/min) = (uCr × uV)/(sCr × 1440)
  1. Where uCr is urine creatinine in mg/dL
  2. Where sCr is serum creatinine in mg/dL
  3. Where uV is 24-h urine volume in mL
  4. Where 1440 represents number of minutes in 24 h

The “adequacy” or “completeness” of the collection is estimated by the urinary volume and creatinine content; creatinine is produced from muscle and excreted at a relatively constant rate. For a 20- to 50-year-old man, creatinine excretion should be 18.5–25.0 mg/kg body weight; for a woman of the same age, it should be 16.5–22.4 mg/kg body weight. For example, an 80-kg man should excrete between ~1500 and 2000 mg of creatinine in an “adequate” collection. Creatinine excretion is also influenced by age and muscle mass. Notably, creatinine is an imperfect measure of glomerular filtration rate (GFR), because it is both filtered by glomeruli and secreted by proximal tubular cells; the relative contribution of tubular secretion increases with advancing renal dysfunction, such that creatinine clearance will provide an overestimate of the “true” GFR in pts with chronic kidney disease. Isotopic markers that are filtered and not secreted (e.g., iothalamate) provide more accurate estimates of GFR.

A formula that allows for an estimate of creatinine clearance in men that accounts for age-related decreases in GFR, body weight, and sex has been derived by Cockcroft-Gault:

Creatinine clearance (mL/min) = (140-age) × lean body weight (kg)/plasma creatinine (mg/dL) × 72

This value should be multiplied by 0.85 for women.

GFR may also be estimated using serum creatinine–based equations derived from the Modification of Diet in Renal Disease Study. This “eGFR” (estimated glomerular filtration rate) is now reported with serum creatinine by most clinical laboratories in the United States and is the basis for the National Kidney Foundation classification of chronic kidney disease (Table 46-1).

Kidney Damage StageDescriptioneGFR (mL/min per 1.73 m2)
0With risk factors for CKDa>90
1With evidence of kidney damageb>90
2Mild decrease in GFR60–89
3Moderate decrease in GFR30–59
4Severe decrease in GFR15–29
5Kidney failure<15
aDiabetes, high blood pressure, family history, older age, African ancestry.
bAbnormal urinalysis, hematuria, proteinuria, albuminuria.
Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.

Manifestations of impaired renal function include volume overload, hypertension, electrolyte abnormalities (e.g., hyperkalemia, hypocalcemia, hyperphosphatemia), metabolic acidosis, and hormonal disturbances (e.g., insulin resistance, functional vitamin D deficiency, secondary hyperparathyroidism). When severe, the symptom complex of “uremia” may develop, encompassing one or more of the following symptoms and signs: anorexia, dysgeusia, nausea, vomiting, lethargy, confusion, asterixis, pleuritis, pericarditis, enteritis, pruritus, sleep and taste disturbance, nitrogenous fetor.

An approach to the pt with azotemia is shown in Fig. 46-1.


Approach to the pt with azotemia. FeNa, fractional excretion of sodium; GBM, glomerular basement membrane. (From Lin J and Denker BM: Chap. 61, p. 289, HPIM-19.)

-- To view the remaining sections of this topic, please or purchase a subscription --


Loscalzo, Joseph, et al., editors. "Azotemia and Urinary Abnormalities." Harrison's Manual of Medicine, 19th ed., McGraw Hill Inc., 2017. harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623184/all/Azotemia_and_Urinary_Abnormalities.
Azotemia and Urinary Abnormalities. In: Loscalzo J, Jameson JL, Longo DL, et al, eds. Harrison's Manual of Medicine. 19th ed. McGraw Hill Inc.; 2017. https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623184/all/Azotemia_and_Urinary_Abnormalities. Accessed April 18, 2019.
Azotemia and Urinary Abnormalities. (2017). In Loscalzo, J., Jameson, J. L., Longo, D. L., Hauser, S. L., Fauci, A. S., & Kasper, D. L. (Eds.), Harrison's Manual of Medicine. Available from https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623184/all/Azotemia_and_Urinary_Abnormalities
Azotemia and Urinary Abnormalities [Internet]. In: Loscalzo J, Jameson JL, Longo DL, Hauser SL, Fauci AS, Kasper DL, editors. Harrison's Manual of Medicine. McGraw Hill Inc.; 2017. [cited 2019 April 18]. Available from: https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623184/all/Azotemia_and_Urinary_Abnormalities.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Azotemia and Urinary Abnormalities ID - 623184 ED - Loscalzo,Joseph, ED - Jameson,J Larry, ED - Longo,Dan L, ED - Hauser,Stephen L, ED - Fauci,Anthony S, ED - Kasper,Dennis L, BT - Harrison's Manual of Medicine UR - https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623184/all/Azotemia_and_Urinary_Abnormalities PB - McGraw Hill Inc. ET - 19 DB - Harrison's Manual of Medicine DP - Unbound Medicine ER -